The reaction of cyanoacetylhydrazine with chloroacetone gave the N-(1-chloropropan-2-ylidene)-2-cyanoacetohydrazide. This compound reacted with either hydrazine hydrate or phenylhydrazine to give the corresponding 1,2,4-triazine derivatives. On the other hand, its reaction with either benzenediazonium chloride or benzaldehyde gave in each case the 1,3,4-oxadiazine derivatives. Moreover, the reaction of the cyanoacetylhydrazine with 2-boromocyclohexanone gave the corresponding hydrazine-hydrozon derivative. The antitumor evaluation of the newly synthesized products against three cancer cell lines, namely breast adenocarcinoma (MCF-7), non-small cell lung cancer (NCI-H460) and CNS cancer (SF-268) was recorded. Some of the tested compounds showed activities which was higher than the reference doxorubicin.
Introduction
It is well known that the hydrazone group plays an important role for the antimicrobial activity. Furthermore, a number of hydrazide-hydrazone claimed to possess interesting antibacterial antifungal [1] [2] [3] anticonvulsant [4] [5] [6] anti-inflammatory [7] [8] [9] antimalarial [10] and antituberculosis activities [11] [12] [13] [14] [15] With the aim of obtaining new hydrazide-hydrazones with such wide spectrum of pharamaceutical applications, we report here the synthesis of a series of hydrazide-hydrzones via the reaction of cyanoacetylhydrazine (1) with -haloketones [16, 17] .
All synthesized compounds have been screened for antitumor activity against breast adenocarcinoma (MCF-7), non-small cell lung cancer (NCI-H460) and CNS cancer (SF-268).
Results and Discussions
The reaction of 1 with chloroacetone (2) in 1,4-dioxane gave the hydrazide-hydrazon derivative 3. The structure of compound 3 was based on the analytical and spectral data. Thus, the 1 H NMR spectrum of the reaction product showed the presence of a singlet at δ 2.36 ppm corresponding to CH 3 group, two singlets at δ 3.37, 4.02 ppm corresponding to two CH 2 groups and a singlet at δ 8.09 ppm for the NH group. Further confirmation for the structure of compound 3 was obtained through studying its reactivity towards some chemical reagents. Thus, the reaction of 3 with either hydrazine hydrate (4a) or phenylhydrazine (4b) gave the 1,2,4 triazine derivatives 6a and 6b, respectively. Formation of the latter products is explained through the intermediate formation of 5a,b followed by water elimination.
The reaction of 6b with benzenediazonium chloride (7) gave the phenyl hydrazone derivative 9 (Scheme 1). The reaction took place through the first coupling of 6 with 7 to give the phenylhydrazone derivative 8 followed by Micheal addition of the N-NH group present in the triazine ring to the cyano group to give the pyrazolo [5-1-c] [1,2,4]triazine derivative 9. On the other hand, the reaction of 6b with either malononitrile (10a) or ethyl cyanoacetate (10b) gave the tricyclic products 11a and 11b, respectively. Analytical and spectral data of 11a,b are consistent with the proposed structures (see experimental section). The reaction of compound 3 with either benzenediazonium chloride 7 or p-chlorobenzenediazonium chloride 12 gave 1,3,4-oxadiazine derivatives 13a and 13b respectively. On the other hand, the reaction of compound 3 with potassium cyanide (14) gave the 3-amino pyrazole derivative 15. Formation of the pyrazole derivative 15 took place in analogous with our recent reported work [18] .
The reaction of compound 3 with benzaldehyde (16) gave the 2-α-benzal acetonitryl-1,3,4-oxadiazine derivatives 18 (Scheme 2) its formation occured through the first formation of the benzal derivative followed by HCl liberation. The 1 HNMR spectrum of the latter product showed the presence of a singlet at δ 2.68 for CH 3 group, a singlet at δ 5.26 for oxadiazine CH 2 group, a singlet at δ 6.05 for CH = C and a multiplet at δ 7.22 -7.35 for C 6 H 5 group.
The reaction of compound 18 with either malononitrile (10a) or ethyl cyanoacetate (10b) gave the pyrido [2,1-b] 1,3,4-oxadiazine derivatives 20a and 20b. The structure elucidation of the latter products was based on analytical and spectral data (see experimental section). Next, we studied the reaction of cyanoacetylhydrazine (1) with 2-bromocyclohexanone (21) in 1,4-dioxane at room temperature. The reaction leads to the formation of the hydrazide-hydrazone derivative 22. The analytical and spectral and spectral data of the latter product are in agreement with the proposed structure (see experimental section).
Compound 22 reacted with either hydrazine hydrate (4a) or phenylhydrazine (4b) to give the tricyclic products 24a and 24b, respectively. The formation of 24a,b was explained in terms of intermediate formation of hydrazono derivatives followed by cyclization to give the intermediates 23a,b, respectively. The latter intermediates underwent further cyclization to give 24a,b. The reaction of 22 with either benzenediazonium chloride (7) kindly provided by the National Cancer Institute (NCI, Cairo, Egypt). They grow as monolayer and rou-tinely maintained in RPMI-1640 medium supplemented with 5% heat inactivated FBS, 2 mM glutamine and antibiotics (penicillin 100 U/mL, streptomycin 100 g/mL), at 37˚C in a humidified atmosphere containing 5% CO 2 .
Exponentially growing cells were obtained by plating 1.5 × 10 5 cells/mL for MCF-7 and SF-268 and 0.75 × 10 4 cells/mL for NCI-H460, followed by 24 h of incubation. The effect of the vehicle solvent (DMSO) on the growth of these cell lines was evaluated in all the experiments by exposing untreated control cells to the maximum con-centration (0.5%) of DMSO used in each assay.
Effect on the Growth of Human Tumor Cell Lines
The effect of compounds 3 -25b was evaluated on the in vitro growth of three human tumor cell lines representing different tumor types, namely, breast adenocarcinoma (MCF-7), non-small cell lung cancer (NCI-H460) and CNS cancer (SF-268), after a continuous exposure of 48 h. The results are summarized in Table 1 . All the compounds were able to inhibit the growth of the human tumor cell lines in a dose dependent manner (data not shown). Compound 11a (7-methyl-9-phenyl-8,9-dihdro-1, 5,6,8a,9-pentaaza-fluorene-2,4-diamine) and 20b
]oxadiazine-7,9-dicarbonitrile) showed the best results, exhibiting an equivalent potency in all the three tumor cell lines; these values are much lower than that of the gram positive control doxorubicin. Compounds 20b and 24b are the following in relation to the anticancer activity.
On the other hand, compounds 3, 6a, 9, 11a, 18, 20a, 22, 24a and 25b showed moderated growth inhibitory effect which showed GI 50 < 30 mol  ·L -1 . Comparing the activities of 20a and 20b it is observed that the 2-amino group in 20a showed a stronger growth inhibitory effect than the 2-hydroxy substituent in 20b although the results in NCI-H460 cell line are comparable. Also comparing compounds 24a and 24b, it is obvious 
Experimental Materials
The requisite starting materials such as chloroacetone, hydrazine hydrate, phenyl hydrazine, sodium nitrite, malononitrile, ethyl cyanoacetate, aniline, p-chloro aniline, potassium cyanide, benzaldehyde, bromocyclohexanone were produced from Aldrich Company and used without any further purification. All the solvents were purified and dried by standard method. All melting points were determined in open capillaries and are uncorrected. IR spectra were measured using KBr discs on a Pye Unicam SP-1000 spectrophotometer.
1 HNMR spectra was measured on a varian EM390-200 MHz instrument in DMSO as solvent using tetramethylsilane (TMS) as internal reference standard. The chemical shifts are quoted as δ ppm.
N-(1-Chloropropan-2-ylidene)-2-cyanoacetohydrazi de (3).
Equimolecular amounts of 1 (0.99 g, 0.01 mol) and chloroacetone (2) (0.92 g, 0.01 mol) in 1,4-dioxane (25 mL) and drops of dimethylformamide (5 mL) were stirred at room temperature for 1 h. The formed solid product was collected by filtration. White crystals from ethanol in a yield 88% (1.52) g and with m.p. 160˚C; Calculated for C 6 General procedure: To a solution of 3 (1.73 g, 0.01 mol) in 1,4-dioxane (30 mL), and either hydrazine hydrate (4a) (0.50 g, 0.01 mol) or phenyl hydrazine (4b) (1.08 g, 0.01 mol) were added. The reaction mixture was kept on ice bath for 10 min. The solid product formed upon dilution with ice/water containing hydrochloric acid (till pH 6 ), was collected by filtration. To a cold solution (0˚C -5˚C) of 6b (2.27 g, 0.01 mol) in ethanol (30 mL) containing sodium hydroxide (10%, 6 mL) benzenediazonium chloride (7) (0.01 mol) [obtained via the addition of sodium nitrite solution (0.70 g, 0.01 mol) to a cold solution (0˚C -5˚C) of aniline (0.93 g, 0.01 mol) in hydrochloric acid (8 mL) was added with continuous stirring ] was added with continuous stirring. The reaction mixture was stirred for an additional 2 h then the formed solid product was collected by filtration. Orange crystals from ethanol in a yield, 80%, (2.65) g, with m.p. 236˚C -240˚C. Calculated for C 18 7-Methyl-9-phenyl-8,9-dihydro-1,5,6,8a,9-pentaazafluorene-2,4-diamine (11a) and 4-Amino-7-methyl-9-phenyl-8,9-dihydro-1,5,6,8a,9-pentaaza-fluoren-2-ol (11b).
General procedure: Equimolecular amounts of 6b (2.27 g, 0.01 mol) and either malononitrile (10a) (0.66 g, 0.01 mol) or ethyl cyanoacetate (10b) (1.13 g, 0.01 mol) were added in 1,4-dioxane (25 mL) containing triethylamine (1.00 mL) were heated under reflux for 4 h. The formed solid product upon dilution with ice/water containing hydrochloric acid (till pH 6 
2-(2-Phenylhydrazono)-2-(5-methyl-6H-1,3,4-oxadi azin-2-yl)acetonitrile (13a) and 2-(2-p-chlorolhydrazono)-2-(5-methyl-6H-1,3,4-oxadiazin-2-yl)acetonitril e (13b).
General procedure: To a cold solution (0˚C -5˚C) of 3 (1.73 g, 0.01 mol) in ethanol (30 mL) containing sodium hydroxide (10%, 6 mL) either benzenediazonium chloride (7) (0.01 mol) or P-chloro benzenediazonium chloride (12) obtained via the addition of sodium nitrite solution (0.70 g, 0.01 mol) to a cold solution (0˚C -5˚C) of aniline or p-chloro aniline (1.27 g, 0.01 mol) (0.01 mol) (0.93 g, 0.01 mol) in hydrochloric acid (8 mL) was added with continuous stirring was added with continuous stirring. The reaction mixture was stirred for an additional 2 h then the formed solid product was collected by filtration. 
3-(5-Amino-3-methyl-1H-pyrazol-1-yl)-3-oxo-propa nenitrile (15).
To a solution compound 3 (1.73 g, 0.01 mol) in ethanol (25 mL) in a water bath at 60˚C potassium cyanide (14) (0.65 g, 0.01 mol) was added with continues stirring. The reaction mixture was left in water bath for 30 min at 60˚C then poured onto a beaker containing ice/water mixture and drops of hydrochloric acid. The formed solid product was collected by filtration and dried. Orange crystals from ethanol in a yield 59% (0.96 g), with m.p. 
2-(5-Methyl-6H-[1,3,4]oxadiazin-2-yl)-3-phenyl-acr ylonitrile (18)
Equimolecular amounts of 3 (1.73 g, 0.01 mol) and benzaldehyde (16) (1.06 g, 0.01 mol) in 1,4-dioxane (30 mL) containing piperidine (1.00 mL) were heated under reflux for 3 h. The solid product formed upon dilution with ice/water containing hydrochloric acid (till pH 6 General procedure: Equimolecular amounts of 18 (2.25 g, 0.01 mol) either malononitrile (10a) (0.66 g, 0.01 mol) or ethyl cyanoactate (10b) were added(1.13 g, 0.01 mol) in 1,4-dioxane (25 mL) containing triethylamine (1.00 mL) were heated under reflux for 4 h. The solid product formed upon dilution with ice/water containing hydrochloric acid (till pH 6 
N'-(2-bromocyclohexylidene)-2-cyanoacetohydrazi de (22).
To a hot solution of cyanoacetylhydrazine (1) (0.99 g, 0.01mol), in 1,4-dioxane (40 mL), α-bromocyclohexanone (21) (1.76 g, 0.01 mol) was added and drops of piperidine (1 mL). The reaction mixture was kept at room temperature with stirring for 1 h and the formed solid product was filtrated off. Orange crystals from 1,4-dioxane in a yield 88% (2.27 g) with m. 4-chlorophenylhydrazono)-2-(5,6,7,8-tetrahydro-4a  H-benzo[e][1,3,4]oxadiazin-3-yl)acetonitrile (25b) .
General procedure: To a cold solution (0˚C -5˚C) of 22 (2.58 g, 0.01 mol) in ethanol (35 mL) containing sodium hydroxide (6 mL, 10%) and a solution of benzenediazonium chloride (0.01 mol) or p-chlorobenzenediazonium chloride (0.01 mol) obtained via the addition of sodium nitrite solution (0.70 g, 0.01 mol) to a cold solution (0˚C -5˚C) of either aniline (0.93 g, 0.01 mol) or p-chloroaniline (1.27 g, 0.01 mol) containing the appropriate amounts of hydrochloric acid (10 mL) was added with continuous stirring] was added with continuous stirring. The reaction mixture was stirred for an additional 2 h then the formed solid product was collected by filtration.
Compound 
Conclusion
The present work describes the synthesis of the new hydrazide-hydrazone derivative 3. The latter was used for the synthesis of a series of heterocyclic products with antitumor activities. Compounds 11a and 20b showed the highest inhibitor effect towards the tested three cancer cells. The work opened the door towards pharmaceutical uses of other hydrazide-hydrazones that could be obtained by the sequence described in this article.
